For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them. Dubbed XEN1101, the new ...

UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Among Dravet syndrome patients in the SKYLINE trial, the median change from baseline in convulsive seizure frequency over the full treatment period was -22.16% with soticlestat and -8.64% with placebo ...

LOUISVILLE, Ky. (WAVE) - In October, 21-year-old Megan Fox could barely walk. She had to be closely watched out of fear of drop seizures brought on by epilepsy. 20 times a day she would collapse ...

Corpus Callosotomy is a surgical treatment for severe epilepsy. Learn about the procedure, side effects, recovery, and risks ...

Jazz Pharmaceuticals plc JAZZ announced new real-world data from the BECOME (BEhavior, COgnition, and More with Epidiolex) caregiver survey that showed a substantial proportion of caregivers of adult ...

More than 1 in 3 people (36%) with epilepsy have said that the stress of the current cost-of-living crisis is leading to an increased number of seizures. The finding, in a survey of 597 people carried ...

Shares of Ovid Therapeutics OVID plunged 76% on Monday after it announced that treatment with soticlestat, its Takeda TAK-partnered investigational epilepsy drug, failed to meet the primary endpoint ...